期刊文献+

大肠杆菌16S rRNA的核酶设计和初步应用 被引量:2

Design and Identification of Antisense Oligonucleotide Targeting to 16S rRNA of E.coli
下载PDF
导出
摘要 针对细菌rRNA研发抑制细菌增殖的新型抗菌素是抗生素研究领域的新课题。细菌rRNA与基因mRNA一样自然形成折叠卷曲高级结构,其结构上可以结合反义核酸的位点即靶点,靶点的阐明是设计有效反义核酸、核酶(ribozyme)和脱氧核酶(DNAzyme)的关键。MAST方法固定16S rRNA,将其与寡核苷酸文库杂交筛选出靶点,获得了大肠杆菌16S rRNA的6个反义核酸结合靶点,并鉴定5个靶点有效,其中1个为高效。5个靶点的反义核酸能在通透性大肠杆菌菌株培养中不同程度地抑制其生长,针对高效靶点的核酶在转化大肠杆菌中表达而抑制其生长。 Targeting rRNA of bacteria is a new strategy for antibiotic agent development. The rRNA such as mRNA are naturally self-folded molecules which expose only limited accessible target-sites for binding. These accessible sites are pivotal for designing the effective antisense oligonucleotides, ribozymes, and DNAzymes. MAST, an RNA accessible site screening method, illustrated 6 accessible sites on 16S rRNA by immobilizing 16S rRNA and hybridizing with oligonucleotide library. 5 of the accessible sites were identified valid, and the antisense oligonucleotides targeted to which showed inhibition effectiveness on the proliferation. Among the 5 target sites, one showed the priority of accessibility. Ribozyme designed to this site showed obvious inhibition to the growth when induced expressing in the transfection E. coll.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2008年第11期48-52,共5页 China Biotechnology
基金 军事医学科学院科技创新启动基金 "重大新药创制"科技重大专项(2008ZXJ09001-014)资助项目
关键词 RNA 反义核酸 位点 大肠杆菌 16S RRNA E. coli 16S rRNA Antisense oligonucleotide Accessible site MAST
  • 相关文献

参考文献12

  • 1Fourmy D, Recht M I, Blanchart S C,et al. Structure of A site of E. coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science, 1996, 274 : 1367 - 1371
  • 2Miyaguchi H, Narita H, Sakamoto K. An antibiotic-binding motif of an RNA fragment derived from the A site related regiono f E. coli 16S rRNA. Nucleic Asids Res, 1996, 24:3700 - 3706
  • 3Gregory S T, Dahlberg A E. Erythromycin resistance mutations in ribosomal proteins L22 and L4 pertub the higher order structure of 23S ribosomal RNA. J Mol Biol, 1999, 289:827 - 834
  • 4Xiong L, Shah S, Mauvais P,et al. Ketolide resistance mutation in domain Ⅱ of 23S rRNA folding required for formation of mucrolide binding site. Mol Microbiol, 1999, 31:633 - 639
  • 5Hansen L H, Mauvais P,Douthwaite S. The macrolide-kelolide antibiotic binding site is formed by structures in domains II and V of 23S rRNA. Mol Microbiol, 1999, 31:623 - 632
  • 6Zhang H, Mao J, Zhou D,et al. mRNA accessible site tagging (MAST) : a novel high throughput method for selecting effective antisense oligonucleotides. Nucleic Acids Research, 2003,31 (14) :e72
  • 7毛建平,王全会,韩慧明,袁国刚,左刚,邵世和,毛秉智.10-23型DNA酶作为鉴定mRNA靶点有效性的新工具[J].中国生物化学与分子生物学报,2005,21(5):622-627. 被引量:4
  • 8毛建平,王全会,施水兰,袁国刚,左刚,崔玉芳,毛秉智.绿色荧光蛋白基因mRNA反义寡核苷酸的筛选和应用[J].中国生物化学与分子生物学报,2005,21(4):529-536. 被引量:6
  • 9Ehresmann C, Stiegler P, Fellner P,et al. The determination of the primary structure of the 16S ribosomal RNA of Escherichia coli. J Biochimie, 1972, 54 (7) , 901 -967
  • 10王全会,毛建平.mRNA靶点筛选方法研究进展[J].中国生物工程杂志,2003,23(3):1-5. 被引量:12

二级参考文献52

  • 1韩慧明,毛建平.siRNA作用效果的靶点依赖性[J].中国生物工程杂志,2004,24(12):6-9. 被引量:5
  • 2毛建平,王全会,施水兰,袁国刚,左刚,崔玉芳,毛秉智.绿色荧光蛋白基因mRNA反义寡核苷酸的筛选和应用[J].中国生物化学与分子生物学报,2005,21(4):529-536. 被引量:6
  • 3[1]Monia B P,Johnston J F,Geiger T,et al.Activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.Nat Med,1996,2,668~675
  • 4[2]Ho S P,Brition D H,Stone B A,et al.Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.Nucleic Acids Res,1996,24,1901~1907
  • 5[3]Ho S P,Bao Y J,Lesher T,et al.Mapping of RNA accessible site for antisense experiments with oligonucleotide libraries.Nat Biotechnol,1998,16,59~63
  • 6[4]Bruice T W,Lima W F.Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.Biochemistry,1997,36,5004~5019
  • 7[5]Matveeva O,Felden B,Audlin S,et al.A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes:correlation with an intracellular pattern and known RNA structures.Nucleic Acids Res,1997,25,5010~5016
  • 8[6]Southern E M,CaseGreen S C,Elder S C,et al.Arrays of complimentary oligouncleotides for analysing the hybridization behaviour of nucleic acids.Nucleic Acids Res,1994,22,1368~1373
  • 9[7]Milner N,Mir K U,Southern E M.Selecting effective antisense reagents on combinatorial oligonucleotide arrays.Nat Biotechnol,1997,15,537~541
  • 10[8]Lima W F,Monia B P,Ecker D J,et al.Implication of RNA structure on antisense oligonucleotide hybridization kinetics.Biochemistry,1992,31,12055~12061

共引文献17

同被引文献29

  • 1毛建平,王全会,施水兰,袁国刚,左刚,崔玉芳,毛秉智.绿色荧光蛋白基因mRNA反义寡核苷酸的筛选和应用[J].中国生物化学与分子生物学报,2005,21(4):529-536. 被引量:6
  • 2刘小卓,杨洁.pRNA——纳米技术在分子基因治疗中的应用[J].世界临床药物,2006,27(3):182-185. 被引量:1
  • 3周辉,卢向阳,田云,黄成江.pRNA的结构、功能及其研究近况[J].遗传,2006,28(9):1180-1184. 被引量:1
  • 4徐凤萍,杨君,冯雪松,安利佳.pRNA:一种安全、稳定、大容量的基因治疗分子载体[J].中国生物工程杂志,2007,27(6):96-100. 被引量:1
  • 5Shu Y, Cinier M, Shu D, et al. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted ceils. Methods. 2011 Feb 12. doi: 10. 1016/j. ymeth. 2011.01. 008.
  • 6Shu Y, Cinier M, Fox SR, et al. Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach. Mol Ther. 2011 Apr, 5. doi:10. 1038/mr. 2011.23.
  • 7Tarapore P, Shu Y, Guo P, et al. Application of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers. Mol Ther, 2011, 19(2) :386-394.
  • 8Zhou J, Shu Y, Guo P, et al. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gpl20 aptamer for cell- type specific delivery and 1-IIV-1 Inhibition. Methods, 2011, 53 ( 1 ) :73-79.
  • 9Abdelmawla S, Guo S, Zhang L, et al.Pharmacological characterization of chemically synthesized monomerie phi29 pRNA nanoparticles for systemic delivery. Mol Ther, 2011, Apr 5. doi: 10. 1038/mr. 2011.35.
  • 10ZhangH, Mao J, Zhou D, et al. mRNA accessible site tagging (MAST) : a noval high throughput method for selecting effective antisense oligonucleotides. Nucleic Acids Research, 2003, 31(14) : e72.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部